NCT03326921 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03326921
Title	HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Fred Hutchinson Cancer Research Center
Indications	acute lymphoblastic leukemia acute biphenotypic leukemia juvenile myelomonocytic leukemia chronic myeloid leukemia acute myeloid leukemia myelodysplastic syndrome chronic myelomonocytic leukemia
Therapies	Cyclophosphamide + Fludarabine HA-1 TCR T cells
Age Groups:	senior \| child
Covered Countries	USA

NCT03326921
Clinical Trial Detail